Forest Labs Strikes Back At Complaint Over Lexapro

Law360, New York (November 20, 2007, 12:00 AM EST) -- Forest Laboratories Inc. on Monday asked a court to dismiss a product liability suit brought by the estate of a 74-year-old man who committed suicide after taking the antidepressant drug Lexapro.

In its answer to the plaintiff’s complaint, filed with the U.S. District Court for the Eastern District of Missouri, Forest said the plaintiff lacked standing and failed to state a claim upon which relief could be granted. Forest added, among other things, that the plaintiff’s claims should be barred by the statute of limitations and...
To view the full article, register now.